Fatty Acid Metabolism Biomechanical Influence
- Imaging
- 18/04/2024
Author ECRI ECRI Institute 29 Broadwater Road Suite 104 Welwyn Garden City AL7 3BQ United Kingdom Tel: +44 (0) 1707 831001 Fax +44 (0) 1707 393138 [email protected] www.ecri.org.uk The report (reproduced in part here) is from a recent Health Technology Forecast from ECRI, which evaluated...
READ MOREAuthors Amy S. Campbell , MD Chief, Breast Imaging Assistant Professor of Radiology MedStar Georgetown University Hospital Department of Radiology Washington, DC USA [email protected] Cherie M. Kuzmiak , DO Chief, Breast Imaging Associate Professor of Radiology...
READ MOREAuthor Dr. Smriti Hari Additional Professor, Department of Radiology All India Institute of Medical Sciences New Delhi, India [email protected] Dr. C. S. Pant Radiologist Col Pant's Imaging Centre New Delhi, India Breast Cancer Incidence, Mortality And Trends in India In...
READ MOREProf. Francesco Sardanelli University of Milan, IRCCS Policlinico San Donato, Milan, Italy President, European Society of Breast Imaging Director, European Network for the Assessment of Imaging in Medicine Prof. Sardanelli,...
READ MOREInterviewee Dr. Nancy Cappello, Ph.D. Executive Director and Founder Are You Dense, Inc & Are You Dense Advocacy, Inc. Woodbury, CT USA [email protected] Interviewed by Claire Pillar Managing Editor HealthManagement Further information...
READ MOREAuthor Raghuraman Madanagopal Analyst Frost & Sullivan Breast cancer is the most common form of cancer in women, and the second leading cause of cancer death in women around the world, after lung cancer. The incidence of breast cancer in women increases dramatically with age, with most breast cancer cases reported in women over the...
READ MOREThe link between a higher survival rate after a diagnosis of breast cancer for high volume hospitals compared to low volume hospitals has been consistently demonstrated over the last ten years. Less frequent are studies on the differences in processes of care between high and low volume providers. In Belgium, a set of 11 process indicators to assess...
READ MOREIts reliance on biomarker evaluation for diagnosis and treatment decisions makes breast cancer care a good example of personalised medicine. In addition to breast cancer biomarkers such as the oestrogen/progesterone receptor and the Ki- 67 proliferation marker, HER2 (Human Epidermal growth factor Receptor 2) has received particular attention...
READ MORERecent evidence suggests that contrast-enhanced breast MRI is becoming an established technique that offers good quality in safety, performance and patient outcomes. In this article, Prof. Francesco Sardanelli, a frequently invited speaker and educator on this topic at international meetings, writes about the growing effectiveness of breast MRI, the...
READ MOREIts reliance on biomarker evaluation for diagnosis and treatment decisions makes breast cancer care a good example of personalised medicine. In addition to breast cancer biomarkers such as the oestrogen/progesterone receptor and the Ki-67 proliferation marker, HER2 (Human Epidermal growth factor Receptor 2) has received particular attention in the...
READ MORE